首页> 外文期刊>AJRI: American Journal of Reproductive Immunology >The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapy.
【24h】

The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapy.

机译:反复流产妇女中Th1和Th2相关趋化因子受体的表达:淋巴细胞免疫治疗的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

PROBLEM: Recurrent miscarriage (RM) is defined as three or more consecutive pregnancy losses prior to the 20th week of gestation. The aim of this study was to investigate the expression of T helper (Th)1- and Th2-related chemokine receptors on CD4(+) T helper and CD8(+) T cytotoxic (Tc) cells in RM and control subjects. The effects of lymphocyte immunotherapy on the balance of Th1/Th2 and Tc1/Tc2 chemokine receptors were further evaluated in RM women. METHOD OF STUDY: The expression of Th1-related (CCR5 and CXCR3) and Th2-related (CCR3 and CCR4) chemokine receptors on CD4(+) or CD8(+) T cells from RM women were analyzed and compared with controls using flow cytometry. The expression of chemokine receptors in RM women was also compared before and after lymphocyte immunotherapy. RESULTS: The ratios of Th1/Th2 and Tc1/Tc2 chemokine receptors were higher in RM women compared to controls. The ratio of Th1/Th2 chemokine receptors was decreased in RM women after immunotherapy, while no significant change was identified in the Tc1/Tc2 after immunotherapy. CONCLUSION: This study indicates the Th1 dominant immune responses in circulation of RM women compared to controls. Moreover, lymphocyte immunotherapy might influence pregnancy outcome via a shift in the balance of the Th1/Th2 chemokine receptors.
机译:问题:反复流产(RM)的定义是在妊娠第20周之前连续流产3次或更多。这项研究的目的是调查RM和对照组受试者CD4(+)T辅助细胞和CD8(+)T细胞毒性(Tc)细胞上T辅助(Th)1-和Th2相关趋化因子受体的表达。在RM妇女中进一步评估了淋巴细胞免疫疗法对Th1 / Th2和Tc1 / Tc2趋化因子受体平衡的影响。研究方法:分析了RM妇女CD4(+)或CD8(+)T细胞上Th1相关(CCR5和CXCR3)和Th2相关(CCR3和CCR4)趋化因子受体的表达,并使用流式细胞仪与对照组进行了比较。 。在淋巴细胞免疫治疗之前和之后,还比较了RM妇女中趋化因子受体的表达。结果:与对照组相比,RM女性中Th1 / Th2和Tc1 / Tc2趋化因子受体的比例更高。免疫治疗后,RM妇女中Th1 / Th2趋化因子受体的比例降低,而免疫治疗后,Tc1 / Tc2的变化无明显变化。结论:这项研究表明,与对照组相比,RM女性血液循环中的Th1优势免疫反应。此外,淋巴细胞免疫疗法可能会通过改变Th1 / Th2趋化因子受体的平衡来影响妊娠结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号